Ambu A/s Class BOMXCOP: AMBU_B

AMBU_B: Strong double-digit growth and margin expansion, with robust outlook despite FX and tariff headwinds

· Issued by Ambu A/s Class B
Watch Ambu A/s Class B explain itAmbu A S Ord (AMBFF) Q3 2026 Earnings Call · Replay · Aug 26

Delivered 13.1% organic revenue growth and 13.0% EBIT margin, driven by strong endoscopy and anesthesia segments. Outlook for 2025-2026 is 10%-13% organic growth and 12%-14% EBIT margin, with tariffs and FX as key headwinds but long-term targets reaffirmed.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

Earlier from Ambu A/s Class B

All Ambu A/s Class B news releases